Monday, 19 September 2016

Astellas, Vical herpes vaccine fails mid-stage study

(Reuters) - Japan's Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)